References
- Fraidenburg DR, Machado RF. Pulmonary hypertension associated with
thalassemia syndromes. Ann NY Acad Sci 2016; 1368:127–139
- Eldor A, Rachmilewitz EA. The hypercoagulable state in thalassemia.
Blood 2002; 99:36–43
- Mahesh B, Besser M, Ravaglioli A, et al . Pulmonary
endarterectomy is effective and safe in patients with
haemoglobinopathies and abnormal red blood cells: the Papworth
experience. Eur J Cardio-Thorac Surg 2016; 50:537–541
- Roggero S, Vullo S, Volpe G, Piga A, Albera C. Management of pulmonary
arterial hypertension associated to thalassemia: when pulmonary
endarterectomy is the best therapeutical option? A case report. J
Thromb Thrombolysis 2015; 39:139-43
- Jamieson SW, Auger WR, Fedullo PF, et al . Experience and
results with 150 pulmonary thromboendarterectomy operations over a
29-month period. J Thorac Cardiovasc Surg 1993; 106:116–127
- Simonneau G, Robbins IM, Beghetti M, et al . Updated clinical
classification of pulmonary hypertension. J Am Coll Cardiol 2009; 54(1
Suppl):S43-54
- Scholzel BE, Post MC, Plokker HT, Snijder RJ. Clinical worsening
during long-term follow-up in inoperable chronic thromboembolic
pulmonary hypertension. Lung 2011; 190:161–167
- Karyofyllis P, Tsiapras D, Papadopoulou V, et al . Balloon
pulmonary angioplasty is a promising option in thalassemic patients
with inoperable chronic thromboembolic pulmonary hypertension. J
Thromb Thrombolysis 2018, 46:516-520